Clinical Trial Update: Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated sequential administration of irinotecan (CPT-11) and mitomycin C in patients with advanced esophageal or gastric cancer and has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Esophageal Cancer, Esophagus Cancer | Phase 2 | Status: COMPLETED